iShares Biotechnology ETF (IBB) Dividend Yield, History & Forecast

iShares Biotechnology ETF (IBB) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 0.16% ($0.34 per share annually (TTM)). The most recent ex-dividend date was September 15, 2026, with payment scheduled for September 18, 2026. market capitalization is approximately $10.36B. Review IBB dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

Loading quote...

IBB fund composition

IBB holds 243 positions, with 47.9% of assets in its ten largest. It charges an expense ratio of 0.44%, and manages $10.68B.

Top 10 holdings

HoldingWeight
AMGNAMGEN INC8.55%
VRTXVERTEX PHARMACEUTICALS8.04%
GILDGILEAD SCIENCES7.33%
REGNREGENERON PHARMACEUTICALS5.85%
MRNAMODERNA3.94%
ARGXARGENX SE ADR3.76%
NTRANATERA3.08%
RVMDREVOLUTION MEDICINES2.81%
ALNYALNYLAM PHARMACEUTICALS2.30%
BIIBBIOGEN2.22%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about iShares Biotechnology ETF (IBB)

What is iShares Biotechnology ETF's dividend yield?
iShares Biotechnology ETF (IBB) pays a current trailing twelve-month dividend yield of 0.16%, which works out to $0.34 per share annually based on the most recent payout schedule.
When does iShares Biotechnology ETF pay its next dividend?
The most recent ex-dividend date was September 15, 2026. The next scheduled dividend payment date is September 18, 2026.
Is iShares Biotechnology ETF a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is iShares Biotechnology ETF in?
iShares Biotechnology ETF (IBB) operates in the Financial Services sector, specifically the Asset Management industry.